Barbara Mentzer, RN | |
260 Crest Rd, Suite 202, Saint Albans, VT 05478-9503 | |
(802) 524-1227 | |
(802) 524-8498 |
Full Name | Barbara Mentzer |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 260 Crest Rd, Saint Albans, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134665888 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 0260034789 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Barbara Mentzer, RN 19 Biscayne Hts, Colchester, VT 05446-6940 Ph: (802) 651-6961 | Barbara Mentzer, RN 260 Crest Rd, Suite 202, Saint Albans, VT 05478-9503 Ph: (802) 524-1227 |
News Archive
During the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa, scientists "renewed the call for more immediate and urgent effort to be directed towards HIV prevention amid the dominance of treatment interventions and the world-wide search for a quick fix vaccine, which many agree, is years away," Health-e/allAfrica.com reports (Thom, 7/22).
The Kansas Health Institute has a package of stories about a malpractice case being considered by the Kansas Supreme Court in which the justices could determine if the state's caps on medical malpractice awards are constitutional. The case involves Amy Miller, who underwent surgery to have an ovary removed. But the surgeon took the wrong ovary and later she had the second one taken out.
KV Pharmaceutical Company ( KVa/KVb) today announced it has entered into an amendment to the existing asset purchase agreement with Hologic, Inc. to secure the full U.S. and worldwide rights to Gestiva(TM), subject to the terms and conditions set forth in the amendment. Upon approval by the U.S. Food and Drug Administration (the "FDA"), Gestiva(TM) will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single baby and have spontaneously delivered a single baby preterm in the past.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Researchers from the UK have found that patients with dementia presenting in primary care with urinary incontinence are significantly more likely to receive pharmacologic treatment or be catheterized than other patients.
› Verified 9 days ago
Ashley Luneau, Registered Nurse Medicare: Medicare Enrolled Practice Location: 11 Crest Rd, Saint Albans, VT 05478 Phone: 802-527-8189 Fax: 802-527-8187 | |
Casara J King, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 270 N Main St, Saint Albans, VT 05478 Phone: 802-370-2099 | |
Gail Jackson Wolff, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Home Health Cir, Saint Albans, VT 05478 Phone: 802-527-7531 |